|
May 15
|
Sanofi: Information concerning the total number of voting rights and shares - April 2025
|
|
May 15
|
French finance minister criticises Sanofi's $20 billion USA investment decision
|
|
May 15
|
Sanofi commits ‘at least $20bn’ to US manufacturing through 2030
|
|
May 15
|
Sanofi to pour more than $20B into US drug research and manufacturing
|
|
May 14
|
France's Sanofi to invest at least $20 billion in US through 2030
|
|
May 14
|
Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing
|
|
May 13
|
Sanofi (SNY): A Bull Case Theory
|
|
May 12
|
Bristol-Myers Squibb, Sanofi Enter $700 Million Settlement With Hawaii in Plavix Lawsuit
|
|
May 12
|
Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower
|
|
May 12
|
Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices
|
|
May 10
|
Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit
|
|
May 9
|
NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up
|
|
Apr 28
|
Private Equity Firms Target Defense Assets Once Seen as Toxic
|
|
Apr 25
|
Swiss Agree to Tariff Negotiations With Trump Administration
|
|
Apr 24
|
Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed
|
|
Apr 24
|
Sanofi axes development of oral TNF inhibitor as monotherapy following Phase II fail
|
|
Apr 24
|
French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit
|
|
Apr 24
|
Sanofi Q1 Earnings Top Estimates, Dupixent Drives Sales Growth
|
|
Apr 24
|
Sanofi stays on course amid tariff turmoil
|
|
Apr 24
|
Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug
|